| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |